NMUS Nemus Bioscience Panel Discussion at ROTH Conference

March 17, 2019 – March 19, 2019 all-day

Nemus Bioscience, Inc. (OTCQB: $NMUS), a biopharmaceutical company focused on bioengineered cannabinoid-based therapeutics to address global medical indications, announced today that CEO and Chief Medical Officer Dr. Brian Murphy will participate in a panel discussion, “Cannabinoid Pharmaceuticals,” at the 31st Annual ROTH Conference being held on March 17-19, 2019, at The Ritz Carlton, Laguna Niguel in Orange County, CA.


Nemus Bioscience to Present at 31st Annual ROTH Conference


Discussion on the $NMUS forum.

Leave a Reply